HomeQuestion

How do you manage worsening cutaneous dermatomyositis when muscle disease appears controlled?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you approach incidental NXP-2 antibody positivity in patients without current clinical evidence of myositis or systemic autoimmune disease?

In patients with anti-PL7 antibody–associated antisynthetase syndrome, can sacroiliitis occur as part of the inflammatory arthritis spectrum, or should alternative causes be considered?

How do you approach selecting optimal muscle biopsy site when evaluating a patient for suspected inflammatory myopathy?

How do you approach management and monitoring of a patient with features suggestive of early or incomplete antisynthetase syndrome (mechanics hands and positive antisynthetase antibody) but no objective evidence of myositis, arthritis, or ILD at presentation?

Is bortezomib associated with drug-induced myopathy?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.